반응식
[NH:1]([C:5]1[CH:14]=[C:13]2[C:8]([C:9]([CH2:16][C:17]3[CH:22]=[CH:21][N:20]=[CH:19][CH:18]=3)=[N:10][N:11]=[C:12]2[Cl:15])=[CH:7][CH:6]=1)[C:2]([CH3:4])=[O:3].[Cl:23][C:24]1[CH:25]=[C:26]([CH:28]=[CH:29][CH:30]=1)[NH2:27]>C(O)CCC>[ClH:15].[NH:1]([C:5]1[CH:14]=[C:13]2[C:8]([C:9]([CH2:16][C:17]3[CH:22]=[CH:21][N:20]=[CH:19][CH:18]=3)=[N:10][N:11]=[C:12]2[NH:27][C:26]2[CH:28]=[CH:29][CH:30]=[C:24]([Cl:23])[CH:25]=2)=[CH:7][CH:6]=1)[C:2]([CH3:4])=[O:3]참가 물질
4
실험 절차
By analogy with Example 25, 300 mg (0.96 mmol) 7-acetamino-1-chloro-4-(4-pyridylmethyl)-phthalazine is reacted in 3.9 ml 1-butanol with 302 μl (2.88 mmol) 3-chloroaniline. Suspension of the raw product in 1 ml boiling ethanol and filtration lead to the title compound: HPLC: tRet(Grad5-40)=11.3; FAB MS (M+H)+=404.
후처리
- filtrationethanol and filtration lead to the title compound
출처 및 근거
- ORD 기록
- ord-9e2ce66826cc481a866d58559b881a2a
- 출처 데이터셋
- uspto-grants-2004_03
- 특허 번호
- US06710047B2
연결된 노트
불러오는 중…